☆ 4.4 Meeting Abstract

POTENTIAL UTILITY OF MRD TO IDENTIFY RELAPSE IN pALL PATIENTS TREATED WITH TISAGENLECLEUCEL

PEDIATRIC BLOOD & CANCER (2019)

Add to Collection

Journal

PEDIATRIC BLOOD & CANCER
Volume 66, Issue -, Pages -

Publisher

WILEY

Keywords

-

Categories

Oncology Hematology Pediatrics

Funding

  1. Novartis

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.